Guyana vs Romania: HIV/AIDS deaths averted by antiretroviral therapy
Guyana
512.85 deaths
in 2024
Romania
514.7 deaths
in 2024
Guyana rank
93rd
Romania rank
92nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Guyana
- Romania
How they compare
Romania currently reports 514.7 deaths against 512.85 deaths in Guyana, a difference of 1.85 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Romania ahead.
Guyana ranks 93rd and Romania ranks 92nd of 157 countries.
Romania has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Guyana | Romania | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 3.23 deaths | 3.23 deaths | Romania |
| 2000s | 139.91 deaths | 441.47 deaths | 301.56 deaths | Romania |
| 2010s | 424.71 deaths | 514.41 deaths | 89.7 deaths | Romania |
| 2020s | 494.78 deaths | 518.81 deaths | 24.03 deaths | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Guyana or Romania?
- Romania, at 514.7 deaths against 512.85 deaths in Guyana as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Guyana and Romania?
- 1.85 deaths, with Romania ahead.
- How many years of comparable data are there for Guyana and Romania?
- 35 years are reported by both, from 1990 to 2024.
- How do Guyana and Romania rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Guyana ranks 93rd and Romania ranks 92nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.